1. Home
  2. CRVL vs SRRK Comparison

CRVL vs SRRK Comparison

Compare CRVL & SRRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRVL
  • SRRK
  • Stock Information
  • Founded
  • CRVL 1987
  • SRRK 2012
  • Country
  • CRVL United States
  • SRRK United States
  • Employees
  • CRVL N/A
  • SRRK N/A
  • Industry
  • CRVL Specialty Insurers
  • SRRK Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • CRVL Finance
  • SRRK Health Care
  • Exchange
  • CRVL Nasdaq
  • SRRK Nasdaq
  • Market Cap
  • CRVL 3.8B
  • SRRK 3.0B
  • IPO Year
  • CRVL 1991
  • SRRK 2018
  • Fundamental
  • Price
  • CRVL $74.96
  • SRRK $41.58
  • Analyst Decision
  • CRVL
  • SRRK Strong Buy
  • Analyst Count
  • CRVL 0
  • SRRK 11
  • Target Price
  • CRVL N/A
  • SRRK $47.30
  • AVG Volume (30 Days)
  • CRVL 162.3K
  • SRRK 2.1M
  • Earning Date
  • CRVL 11-04-2025
  • SRRK 11-14-2025
  • Dividend Yield
  • CRVL N/A
  • SRRK N/A
  • EPS Growth
  • CRVL 28.11
  • SRRK N/A
  • EPS
  • CRVL 2.02
  • SRRK N/A
  • Revenue
  • CRVL $933,841,000.00
  • SRRK N/A
  • Revenue This Year
  • CRVL N/A
  • SRRK N/A
  • Revenue Next Year
  • CRVL N/A
  • SRRK $1,987.65
  • P/E Ratio
  • CRVL $36.58
  • SRRK N/A
  • Revenue Growth
  • CRVL 10.43
  • SRRK N/A
  • 52 Week Low
  • CRVL $70.47
  • SRRK $22.71
  • 52 Week High
  • CRVL $128.61
  • SRRK $46.98
  • Technical
  • Relative Strength Index (RSI)
  • CRVL 50.20
  • SRRK 69.74
  • Support Level
  • CRVL $71.25
  • SRRK $37.54
  • Resistance Level
  • CRVL $78.86
  • SRRK $39.50
  • Average True Range (ATR)
  • CRVL 2.14
  • SRRK 2.22
  • MACD
  • CRVL 0.05
  • SRRK 1.24
  • Stochastic Oscillator
  • CRVL 44.02
  • SRRK 86.59

About CRVL CorVel Corp.

CorVel Corp applies technology including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. It partners with employers, third-party administrators, insurance companies, and government agencies in managing worker's compensation and health, auto, and liability services. The company's solutions combine integrated technologies with a human touch providing services that include claims management, bill review, preferred provider networks, utilization management, case management, pharmacy services, directed care, and medicare services.

About SRRK Scholar Rock Holding Corporation

Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions.

Share on Social Networks: